glp 1 age restrictions Prescriptions for Obesity Medications Among Adolescents Aged 12–17 Years with Obesity — United States, 2018–2023 Medicare Bridge Program Explained: GLP-1

Injectable tirzepatide achieves higher blood concentrations more reliably than oral formulations, making it slightly more potent for most patients

For the small cohort of AOM patients who do switch, tirzepatide is the most common agent, and nearly half opt to pay cash for Zepbound, often through LillyDirects direct-to-consumer platform

found no improvements in bone strength or microarchitecture with liraglutide, suggesting that the effects of GLP-1 receptor agonists on bone remodeling may be context-dependent and influenced by metabolic conditions

It is HSA/FSA eligible and available in all 50 states

I am an endocrinologist by training and spent 20 years researching diabetes and obesity at Indiana University while also seeing patients